HOME › DRUGS › AMPICILLIN SODIUM
ACTIVE SUBSTANCE / INN

AMPICILLIN SODIUM

Brand name(s): TOTACILLIN-N, UNASYN, AMPICILLIN SODIUM, POLYCILLIN-N, AMPICILLIN AND SULBACTAM, PENBRITIN-S, OMNIPEN-N
FDA LISTED
PRESCRIPTION
DISCONTINUED
NDA050309
ANDA090653
ACTIVE SUBSTANCE
Ampicillin Sodium
REGULATORS
FDA
SPONSORS / MAH
WYETH AYERST, HOSPIRA, BRISTOL
TOTAL APPLICATIONS
10
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
AMPICILLIN AND SULBACTAMANDA090339EUGIA PHARMA SPECLTSPrescription
AMPICILLIN AND SULBACTAMANDA090653HOSPIRA INCDiscontinued
AMPICILLIN SODIUMANDA090889ACS DOBFAR SPAPrescription
AMPICILLIN SODIUMANDA202865HOSPIRADiscontinued
OMNIPEN-NANDA060626WYETH AYERSTDiscontinued
UNASYNANDA062901PFIZERDiscontinued
TOTACILLIN-NANDA062727GLAXOSMITHKLINEDiscontinued
POLYCILLIN-NNDA050309BRISTOLDiscontinued
UNASYNNDA050608PFIZERPrescription
PENBRITIN-SNDA050072WYETH AYERSTDiscontinued

FULL INTELLIGENCE ON AMPICILLIN SODIUM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →